| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000278 | Mitotic cell cycle | Decreases phenotype | PMID:11479202 |
| GO:0000723 | Telomere maintenance | Affects phenotype | PMID:33022284 |
| GO:0001516 | Prostaglandin biosynthetic process | Increases phenotype | PMID:27697457 |
| GO:0001523 | Retinoid metabolic process | Affects phenotype | PMID:33607186 |
| GO:0001541 | Ovarian follicle development | Affects phenotype | PMID:31063829; PMID:32234510 |
| GO:0001649 | Osteoblast differentiation | Decreases phenotype | PMID:36370075 |
| GO:0001825 | Blastocyst formation | Decreases phenotype | PMID:36029422 |
| GO:0001837 | Epithelial to mesenchymal transition | Affects phenotype | PMID:26971374 |
| GO:0001890 | Placenta development | Decreases phenotype | PMID:24475139 |
| GO:0001944 | Vasculature development | Decreases phenotype | PMID:24475139 |
| GO:0002248 | Connective tissue replacement involved in inflammatory response wound healing | Increases phenotype | PMID:27613713 |
| GO:0002250 | Adaptive immune response | Affects phenotype | PMID:24194396 |
| GO:0002283 | Neutrophil activation involved in immune response | Increases phenotype | PMID:24194396 |
| GO:0002286 | T cell activation involved in immune response | Affects phenotype | PMID:24194396; PMID:27783946 |
| GO:0002326 | B cell lineage commitment | Decreases phenotype | PMID:28049042 |
| GO:0002360 | T cell lineage commitment | Decreases phenotype | PMID:27590929 |
| GO:0002377 | Immunoglobulin production | Decreases phenotype | PMID:27473338 |
| GO:0002381 | Immunoglobulin production involved in immunoglobulin-mediated immune response | Affects phenotype | PMID:24051191; PMID:24713691; PMID:29860352 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:26278112; PMID:26862745; PMID:28302560 |
| GO:0002532 | Production of molecular mediator involved in inflammatory response | Increases phenotype | PMID:24154488 |
| GO:0002534 | Cytokine production involved in inflammatory response | Increases phenotype | PMID:27613713 |
| GO:0002638 | Negative regulation of immunoglobulin production | Increases phenotype | PMID:29462421 |
| GO:0002639 | Positive regulation of immunoglobulin production | Increases phenotype | PMID:22491429; PMID:27535091; PMID:27590929 |
| GO:0002693 | Positive regulation of cellular extravasation | Increases phenotype | PMID:27713108; PMID:28213091 |
| GO:0002763 | Positive regulation of myeloid leukocyte differentiation | Decreases phenotype | PMID:27590929 |
| GO:0002924 | Negative regulation of humoral immune response mediated by circulating immunoglobulin | Increases phenotype | PMID:29462421 |
| GO:0003014 | Renal system process | Affects phenotype | PMID:30790002 |
| GO:0003993 | Acid phosphatase activity | Increases phenotype | PMID:32031418 |
| GO:0004035 | Alkaline phosphatase activity | Affects phenotype | PMID:28011154; PMID:30203000; PMID:31887333; PMID:32031418 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:32031418 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:32031418 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:32031418 |
| GO:0006006 | Glucose metabolic process | Increases phenotype | PMID:31520823; PMID:37115651 |
| GO:0006123 | Mitochondrial electron transport, cytochrome c to oxygen | Decreases phenotype | PMID:30165701 |
| GO:0006264 | Mitochondrial dna replication | Increases phenotype | PMID:33677009 |
| GO:0006306 | Dna methylation | Affects phenotype | PMID:21212295; PMID:33449811 |
| GO:0006308 | Dna catabolic process | Increases phenotype | PMID:17669606 |
| GO:0006309 | Apoptotic dna fragmentation | Affects phenotype | PMID:16213648; PMID:19520675; PMID:19520675; PMID:8640813; PMID:21534955; PMID:2543382; PMID:9070360; PMID:9677421 |
| GO:0006349 | Regulation of gene expression by genomic imprinting | Affects phenotype | PMID:26455773 |
| GO:0006355 | Regulation of dna-templated transcription | Increases phenotype | PMID:25975270; PMID:25975270; PMID:29873790; PMID:29873790 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:38013089 |
| GO:0006606 | Protein import into nucleus | Increases phenotype | PMID:21652769 |
| GO:0006690 | Icosanoid metabolic process | Increases phenotype | PMID:32387183 |
| GO:0006691 | Leukotriene metabolic process | Increases phenotype | PMID:32387183 |
| GO:0006692 | Prostanoid metabolic process | Increases phenotype | PMID:32387183 |
| GO:0006695 | Cholesterol biosynthetic process | Increases phenotype | PMID:26278112; PMID:28238261 |
| GO:0006703 | Estrogen biosynthetic process | Decreases phenotype | PMID:30172648 |
| GO:0006725 | Cellular aromatic compound metabolic process | Increases phenotype | PMID:15087167 |
| GO:0006741 | Nadp biosynthetic process | Increases phenotype | PMID:26582802 |
| GO:0006782 | Protoporphyrinogen ix biosynthetic process | Increases phenotype | PMID:28213091 |
| GO:0006805 | Xenobiotic metabolic process | Increases phenotype | PMID:29162470 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:24469321; PMID:27697457 |
| GO:0006915 | Apoptotic process | Affects phenotype | PMID:10527913; PMID:14718643; PMID:18958664; PMID:20715097; PMID:30499018; PMID:9070360; PMID:10783307; PMID:11309286; PMID:12668121; PMID:16213648; PMID:11309286; PMID:12373453; PMID:18334599; PMID:9772099; PMID:12668121; PMID:12878042; PMID:14728976; PMID:15093247; PMID:19520675; PMID:15664267; PMID:16125745; PMID:16213648; PMID:17823287; PMID:18172213; PMID:18334599; PMID:19167453; PMID:19520675; PMID:20715097; PMID:21534955; PMID:24932542; PMID:24954032; PMID:29885354; PMID:30172648; PMID:31776611; PMID:32234510; PMID:40024514; PMID:8640813; PMID:9677421; PMID:9751521 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:10771135; PMID:10771135; PMID:11521753; PMID:11979421; PMID:2251677; PMID:10774821; PMID:10774821; PMID:20634294; PMID:11781075; PMID:11836019; PMID:11914781; PMID:12734642; PMID:12355564; PMID:12734642; PMID:15213807; PMID:16226770; PMID:17669606; PMID:18467041; PMID:20634294; PMID:21534955; PMID:8983165; PMID:9538044 |
| GO:0007049 | Cell cycle | Decreases phenotype | PMID:11000096; PMID:15157999; PMID:16636136; PMID:23196670; PMID:9712901 |
| GO:0007204 | Positive regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:28836330 |
| GO:0007281 | Germ cell development | Decreases phenotype | PMID:30172648 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:12355564; PMID:27713107; PMID:32031418 |
| GO:0007530 | Sex determination | Affects phenotype | PMID:32335222 |
| GO:0007565 | Female pregnancy | Affects phenotype | PMID:37854252 |
| GO:0007566 | Embryo implantation | Decreases phenotype | PMID:32031418 |
| GO:0007612 | Learning | Affects phenotype | PMID:33956508 |
| GO:0007625 | Grooming behavior | Decreases phenotype | PMID:38838945 |
| GO:0008203 | Cholesterol metabolic process | Increases phenotype | PMID:23756648; PMID:28238261 |
| GO:0008206 | Bile acid metabolic process | Increases phenotype | PMID:28487374 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:32986415 |
| GO:0008217 | Regulation of blood pressure | Increases phenotype | PMID:18670907; PMID:20634294 |
| GO:0008219 | Cell death | Affects phenotype | PMID:12373453; PMID:16226770; PMID:17669606; PMID:18996433; PMID:26275813; PMID:2734791; PMID:2763295; PMID:8658555 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:10411295; PMID:15157999; PMID:15465647; PMID:2278856; PMID:8384872; PMID:16636136; PMID:17978469; PMID:20623010; PMID:2278856; PMID:24231000; PMID:24932542; PMID:25194622; PMID:26275813; PMID:26860701; PMID:26971374; PMID:27117977; PMID:27312872; PMID:29935225; PMID:7588483; PMID:7826659 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:25843524; PMID:27590929; PMID:31536130 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:24013123; PMID:28836330; PMID:29626627; PMID:39401686 |
| GO:0008360 | Regulation of cell shape | Decreases phenotype | PMID:26454884 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:32031418 |
| GO:0008585 | Female gonad development | Affects phenotype | PMID:32234510 |
| GO:0008610 | Lipid biosynthetic process | Decreases phenotype | PMID:27544633; PMID:28011154 |
| GO:0009744 | Response to sucrose | Decreases phenotype | PMID:38838945 |
| GO:0009749 | Response to glucose | Decreases phenotype | PMID:29175711 |
| GO:0010468 | Regulation of gene expression | Affects phenotype | PMID:33017471 |
| GO:0010507 | Negative regulation of autophagy | Increases phenotype | PMID:39401686 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:28836330 |
| GO:0010693 | Negative regulation of alkaline phosphatase activity | Increases phenotype | PMID:30203000 |
| GO:0010714 | Positive regulation of collagen metabolic process | Increases phenotype | PMID:29673856 |
| GO:0010759 | Positive regulation of macrophage chemotaxis | Increases phenotype | PMID:28213091 |
| GO:0010877 | Lipid transport involved in lipid storage | Decreases phenotype | PMID:32044341 |
| GO:0010890 | Positive regulation of sequestering of triglyceride | Increases phenotype | PMID:27713108 |
| GO:0010891 | Negative regulation of sequestering of triglyceride | Increases phenotype | PMID:32044341 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Decreases phenotype | PMID:28836330 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:25686467; PMID:27392949 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:29140133 |
| GO:0016477 | Cell migration | Affects phenotype | PMID:26275813; PMID:27697457 |
| GO:0019217 | Regulation of fatty acid metabolic process | Increases phenotype | PMID:28487374 |
| GO:0019369 | Arachidonic acid metabolic process | Increases phenotype | PMID:32387183 |
| GO:0019432 | Triglyceride biosynthetic process | Affects phenotype | PMID:23756648; PMID:26278112; PMID:26862745; PMID:26862745; PMID:28238261; PMID:28433925; PMID:28774668; PMID:30722647 |
| GO:0019722 | Calcium-mediated signaling | Increases phenotype | PMID:18172213; PMID:18996433; PMID:19167453; PMID:7826659 |
| GO:0022604 | Regulation of cell morphogenesis | Decreases phenotype | PMID:26454884 |
| GO:0023019 | Signal transduction involved in regulation of gene expression | Affects phenotype | PMID:23419638 |
| GO:0030041 | Actin filament polymerization | Increases phenotype | PMID:27697457 |
| GO:0030154 | Cell differentiation | Increases phenotype | PMID:12883080; PMID:18483191; PMID:18670907; PMID:19490989; PMID:20715097; PMID:21296099; PMID:2734791; PMID:2763295; PMID:2998748; PMID:7588483 |
| GO:0030183 | B cell differentiation | Decreases phenotype | PMID:24709672 |
| GO:0030217 | T cell differentiation | Decreases phenotype | PMID:24709672; PMID:25051576; PMID:26495820 |
| GO:0030225 | Macrophage differentiation | Increases phenotype | PMID:32796029 |
| GO:0030282 | Bone mineralization | Decreases phenotype | PMID:31887333 |
| GO:0030334 | Regulation of cell migration | Decreases phenotype | PMID:26454884 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:33027880 |
| GO:0030501 | Positive regulation of bone mineralization | Increases phenotype | PMID:29673856 |
| GO:0030595 | Leukocyte chemotaxis | Increases phenotype | PMID:19571490 |
| GO:0031324 | Negative regulation of cellular metabolic process | Increases phenotype | PMID:29908305 |
| GO:0031394 | Positive regulation of prostaglandin biosynthetic process | Increases phenotype | PMID:32044341 |
| GO:0031424 | Keratinization | Increases phenotype | PMID:24576722 |
| GO:0032310 | Prostaglandin secretion | Increases phenotype | PMID:30790002 |
| GO:0032733 | Positive regulation of interleukin-10 production | Affects phenotype | PMID:22491429 |
| GO:0032736 | Positive regulation of interleukin-13 production | Affects phenotype | PMID:22491429 |
| GO:0032740 | Positive regulation of interleukin-17 production | Increases phenotype | PMID:22491429; PMID:29040756 |
| GO:0032754 | Positive regulation of interleukin-5 production | Affects phenotype | PMID:22491429 |
| GO:0032782 | Bile acid secretion | Affects phenotype | PMID:29452137 |
| GO:0032829 | Regulation of cd4-positive, cd25-positive, alpha-beta regulatory t cell differentiation | Affects phenotype | PMID:29040756 |
| GO:0032831 | Positive regulation of cd4-positive, cd25-positive, alpha-beta regulatory t cell differentiation | Increases phenotype | PMID:24586378 |
| GO:0032966 | Negative regulation of collagen biosynthetic process | Increases phenotype | PMID:28836330 |
| GO:0033077 | T cell differentiation in thymus | Affects phenotype | PMID:16545771; PMID:30499018 |
| GO:0033559 | Unsaturated fatty acid metabolic process | Increases phenotype | PMID:32387183 |
| GO:0034753 | Nuclear aryl hydrocarbon receptor complex | Increases phenotype | PMID:25265996; PMID:31225620 |
| GO:0035264 | Multicellular organism growth | Decreases phenotype | PMID:28487374 |
| GO:0035265 | Organ growth | Decreases phenotype | PMID:25500125 |
| GO:0035332 | Positive regulation of hippo signaling | Increases phenotype | PMID:25843524 |
| GO:0035938 | Estradiol secretion | Decreases phenotype | PMID:31063829 |
| GO:0036037 | Cd8-positive, alpha-beta t cell activation | Decreases phenotype | PMID:36847456 |
| GO:0036145 | Dendritic cell homeostasis | Affects phenotype | PMID:26377647 |
| GO:0036269 | Swimming behavior | Decreases phenotype | PMID:38838945 |
| GO:0036343 | Psychomotor behavior | Affects phenotype | PMID:33956508 |
| GO:0036378 | Calcitriol biosynthetic process from calciol | Increases phenotype | PMID:29673856 |
| GO:0040015 | Negative regulation of multicellular organism growth | Increases phenotype | PMID:32387183 |
| GO:0042110 | T cell activation | Affects phenotype | PMID:25051576; PMID:33449811 |
| GO:0042167 | Heme catabolic process | Increases phenotype | PMID:28213091 |
| GO:0042310 | Vasoconstriction | Increases phenotype | PMID:27492226 |
| GO:0042311 | Vasodilation | Increases phenotype | PMID:20634294 |
| GO:0042531 | Positive regulation of tyrosine phosphorylation of stat protein | Affects phenotype | PMID:23639249 |
| GO:0042541 | Hemoglobin biosynthetic process | Increases phenotype | PMID:23369756 |
| GO:0042593 | Glucose homeostasis | Decreases phenotype | PMID:28213091 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:25843524; PMID:28213091; PMID:28836330; PMID:31536130; PMID:32283119 |
| GO:0043149 | Stress fiber assembly | Increases phenotype | PMID:27697457 |
| GO:0043456 | Regulation of pentose-phosphate shunt | Increases phenotype | PMID:26582802 |
| GO:0043525 | Positive regulation of neuron apoptotic process | Increases phenotype | PMID:36782369 |
| GO:0044027 | Hypermethylation of cpg island | Increases phenotype | PMID:24136580; PMID:33849548 |
| GO:0044028 | Dna hypomethylation | Increases phenotype | PMID:28011154 |
| GO:0044029 | Hypomethylation of cpg island | Increases phenotype | PMID:33849548 |
| GO:0044030 | Regulation of dna methylation | Affects phenotype | PMID:29550351; PMID:33017471 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:31887333; PMID:32031418; PMID:33387578; PMID:39880321; PMID:40024514 |
| GO:0044849 | Estrous cycle | Affects phenotype | PMID:30172648; PMID:31063829 |
| GO:0045087 | Innate immune response | Affects phenotype | PMID:24194396 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:11781075; PMID:27105554 |
| GO:0045444 | Fat cell differentiation | Affects phenotype | PMID:30203000 |
| GO:0045578 | Negative regulation of b cell differentiation | Increases phenotype | PMID:25543051 |
| GO:0045579 | Positive regulation of b cell differentiation | Decreases phenotype | PMID:28049042 |
| GO:0045597 | Positive regulation of cell differentiation | Affects phenotype | PMID:23639249 |
| GO:0045599 | Negative regulation of fat cell differentiation | Increases phenotype | PMID:29673856 |
| GO:0045600 | Positive regulation of fat cell differentiation | Increases phenotype | PMID:32044341 |
| GO:0045668 | Negative regulation of osteoblast differentiation | Increases phenotype | PMID:30203000 |
| GO:0045669 | Positive regulation of osteoblast differentiation | Affects phenotype | PMID:25795401; PMID:29673856 |
| GO:0045793 | Positive regulation of cell size | Increases phenotype | PMID:19969063 |
| GO:0045814 | Negative regulation of gene expression, epigenetic | Increases phenotype | PMID:26455773 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:24013123 |
| GO:0046325 | Negative regulation of glucose import | Increases phenotype | PMID:32044341 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:10771135; PMID:10771135; PMID:3359422; PMID:3378510; PMID:6838590; PMID:10774821; PMID:11836019; PMID:11914781; PMID:12734642; PMID:12355564; PMID:12734642; PMID:15213807; PMID:18996433; PMID:2251677; PMID:2251677; PMID:2362077; PMID:2554534; PMID:2251677; PMID:3114917; PMID:6661579; PMID:2362077; PMID:28836330; PMID:3020934; PMID:3114917; PMID:3378510; PMID:6506766; PMID:6661579; PMID:8296318; PMID:8983165; PMID:9538044 |
| GO:0046513 | Ceramide biosynthetic process | Increases phenotype | PMID:28238261; PMID:34627992 |
| GO:0046620 | Regulation of organ growth | Affects phenotype | PMID:11836019; PMID:12355564; PMID:11836019; PMID:12355564; PMID:1462355; PMID:12355564; PMID:16125745; PMID:6661579 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:32387183 |
| GO:0046622 | Positive regulation of organ growth | Affects phenotype | PMID:28487374; PMID:29452137; PMID:32387183 |
| GO:0046627 | Negative regulation of insulin receptor signaling pathway | Increases phenotype | PMID:32044341 |
| GO:0046649 | Lymphocyte activation | Increases phenotype | PMID:21212295 |
| GO:0046944 | Protein carbamoylation | Decreases phenotype | PMID:38013089 |
| GO:0048023 | Positive regulation of melanin biosynthetic process | Increases phenotype | PMID:28029781 |
| GO:0048302 | Regulation of isotype switching to igg isotypes | Affects phenotype | PMID:38526216 |
| GO:0048539 | Bone marrow development | Decreases phenotype | PMID:29673856 |
| GO:0048666 | Neuron development | Decreases phenotype | PMID:36782369 |
| GO:0048733 | Sebaceous gland development | Decreases phenotype | PMID:28973660; PMID:31225620 |
| GO:0048771 | Tissue remodeling | Increases phenotype | PMID:24576722 |
| GO:0048873 | Homeostasis of number of cells within a tissue | Affects phenotype | PMID:16545771 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:34129049 |
| GO:0050869 | Negative regulation of b cell activation | Affects phenotype | PMID:25543051 |
| GO:0050871 | Positive regulation of b cell activation | Decreases phenotype | PMID:27546522 |
| GO:0051353 | Positive regulation of oxidoreductase activity | Increases phenotype | PMID:33811995 |
| GO:0051607 | Defense response to virus | Decreases phenotype | PMID:36847456 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Decreases phenotype | PMID:18172213; PMID:18334599 |
| GO:0055008 | Cardiac muscle tissue morphogenesis | Decreases phenotype | PMID:26139165 |
| GO:0055072 | Iron ion homeostasis | Decreases phenotype | PMID:28213091 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:26988466 |
| GO:0060021 | Roof of mouth development | Affects phenotype | PMID:32633565; PMID:40024514 |
| GO:0060179 | Male mating behavior | Affects phenotype | PMID:32031418 |
| GO:0060242 | Contact inhibition | Affects phenotype | PMID:23196670 |
| GO:0060244 | Negative regulation of cell proliferation involved in contact inhibition | Decreases phenotype | PMID:25843524 |
| GO:0060261 | Positive regulation of transcription initiation by rna polymerase ii | Affects phenotype | PMID:23419638 |
| GO:0060444 | Branching involved in mammary gland duct morphogenesis | Increases phenotype | PMID:23212921 |
| GO:0060513 | Prostatic bud formation | Affects phenotype | PMID:19805408; PMID:24928892; PMID:29935225 |
| GO:0060613 | Fat pad development | Affects phenotype | PMID:28774668 |
| GO:0060763 | Mammary duct terminal end bud growth | Affects phenotype | PMID:24136580 |
| GO:0061370 | Testosterone biosynthetic process | Decreases phenotype | PMID:17107848; PMID:32031418 |
| GO:0061450 | Trophoblast cell migration | Increases phenotype | PMID:34747641 |
| GO:0061519 | Macrophage homeostasis | Affects phenotype | PMID:26377647 |
| GO:0062009 | Secondary palate development | Decreases phenotype | PMID:39401686 |
| GO:0065004 | Protein-dna complex assembly | Increases phenotype | PMID:25082669 |
| GO:0070168 | Negative regulation of biomineral tissue development | Increases phenotype | PMID:28836330 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:28302560 |
| GO:0070341 | Fat cell proliferation | Increases phenotype | PMID:25909471 |
| GO:0070455 | Positive regulation of heme biosynthetic process | Increases phenotype | PMID:28213091 |
| GO:0070527 | Platelet aggregation | Increases phenotype | PMID:25797602 |
| GO:0070874 | Negative regulation of glycogen metabolic process | Increases phenotype | PMID:27562557 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:32031418 |
| GO:0071736 | Igg immunoglobulin complex, circulating | Increases phenotype | PMID:38526216 |
| GO:0071902 | Positive regulation of protein serine/threonine kinase activity | Increases phenotype | PMID:28070105 |
| GO:0072201 | Negative regulation of mesenchymal cell proliferation | Increases phenotype | PMID:32283119; PMID:33812962 |
| GO:0072582 | 17-beta-hydroxysteroid dehydrogenase (nadp+) activity | Decreases phenotype | PMID:32031418 |
| GO:0086004 | Regulation of cardiac muscle cell contraction | Decreases phenotype | PMID:24058054; PMID:26572662 |
| GO:0097237 | Cellular response to toxic substance | Affects phenotype | PMID:24355419 |
| GO:0097251 | Leukotriene b4 biosynthetic process | Increases phenotype | PMID:27697457; PMID:28487374 |
| GO:0097272 | Ammonium homeostasis | Affects phenotype | PMID:38013089 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:27713107; PMID:32031418 |
| GO:0098582 | Innate vocalization behavior | Affects phenotype | PMID:29445839 |
| GO:0098586 | Cellular response to virus | Increases phenotype | PMID:33449811 |
| GO:0098801 | Regulation of renal system process | Affects phenotype | PMID:26865671 |
| GO:0102727 | 3beta-hydroxysteroid dehydrogenase activity | Decreases phenotype | PMID:32031418 |
| GO:0120055 | Small intestinal transit | Decreases phenotype | PMID:36782369 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:36534932 |
| GO:0140059 | Dendrite arborization | Increases phenotype | PMID:33956508 |
| GO:1901522 | Positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus | Increases phenotype | PMID:26022396 |
| GO:1903012 | Positive regulation of bone development | Increases phenotype | PMID:29673856 |
| GO:1903047 | Mitotic cell cycle process | Increases phenotype | PMID:27312872 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Affects phenotype | PMID:26495820 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:28836330; PMID:36534932 |
| GO:1903488 | Negative regulation of lactation | Increases phenotype | PMID:25265996 |
| GO:1904178 | Negative regulation of adipose tissue development | Increases phenotype | PMID:29673856 |
| GO:1904251 | Regulation of bile acid metabolic process | Decreases phenotype | PMID:29452137 |
| GO:1904613 | Cellular response to 2,3,7,8-tetrachlorodibenzodioxine | Increases phenotype | PMID:25975270 |
| GO:1904674 | Positive regulation of somatic stem cell population maintenance | Decreases phenotype | PMID:28049042 |
| GO:2000077 | Negative regulation of type b pancreatic cell development | Increases phenotype | PMID:37115651 |
| GO:2000082 | Regulation of l-ascorbic acid biosynthetic process | Increases phenotype | PMID:27562557 |
| GO:2000216 | Positive regulation of proline metabolic process | Increases phenotype | PMID:27562557 |
| GO:2000253 | Positive regulation of feeding behavior | Increases phenotype | PMID:32784060 |
| GO:2000391 | Positive regulation of neutrophil extravasation | Increases phenotype | PMID:28487374 |
| GO:2000491 | Positive regulation of hepatic stellate cell activation | Increases phenotype | PMID:27693115 |
| GO:2000726 | Negative regulation of cardiac muscle cell differentiation | Increases phenotype | PMID:24058054 |
| GO:2001171 | Positive regulation of atp biosynthetic process | Decreases phenotype | PMID:28070105 |
| GO:2001205 | Negative regulation of osteoclast development | Increases phenotype | PMID:29673856 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.